Skip the primary navigation if you do not want to read it as the next section.
Skip the main content if you do not want to read it as the next section.
New treatment offers hope to reducing epilepsy birth defects
A new biochemical approach by Researchers at Royal Holloway, University of London has identified epilepsy treatments that offer stronger seizure protection plus potentially provide safer treatment for pregnant women.
Research carried out by Dr Robin Williams from the Centre of Biomedical Sciences at Royal Holloway, in collaboration with Professor Matthew Walker from the Institute of Neurology, University College London, is published of the latest edition of the Journal Disease, Models and Mechanisms.
Dr Williams said: "The identification of a new family of highly potent anti-epilepsy drugs is an important breakthrough and may provide effective treatments for millions of people world-wide who continue to have uncontrolled seizures.
"This could also help transform the lives of pregnant epileptic women who can continue controlling their seizures with a reduced risk of any defects to their unborn babies."